Evidence map›Paper›PMID 40963393›Full record

ArticleHaematologica2026

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.

Kathelijn Verdeyen, Tom Reuvekamp, Walter J F M Van der Velden, Bas J Wouters, Peter A Von dem Borne, Anna Van Rhenen, Birgit I Lissenberg-Witte, Daniëlle Van Lammeren, Geerte L Van Sluis, Eva De Jongh and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kathelijn VerdeyenAmsterdam UMC location Universiteit van Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam.
Tom ReuvekampAmsterdam UMC location Universiteit van Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam.
Walter J F M Van der VeldenRadboud University Medical Center, Department of Hematology, Nijmegen.
Bas J WoutersErasmus Medical Center, Department of Hematology, Rotterdam.
Peter A Von dem BorneLeiden University Medical Center, Department of Hematology, Leiden.
Anna Van RhenenUniversity Medical Center Utrecht, Department of Hematology, Utrecht.
Birgit I Lissenberg-WitteAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam.
Daniëlle Van LammerenHagaZiekenhuis, Department of Hematology, The Hague.
Geerte L Van SluisIsala Clinics, Department of Internal Medicine, Zwolle.
Eva De JonghAlbert Schweitzer Hospital, Department of Internal Medicine, Dordrecht.
Roel B FietsAmphia Hospital, Department of Internal Medicine, Breda.
Maarten F CorstenMeander Medical Center, Department of Hematology, Amersfoort.
Arie C Van der SpekNorthwest Clinics, Department of Internal Medicine, Alkmaar.
Anke M GerritsOLVG, Department of Internal Medicine, Amsterdam.
Esther R Van BladelSlingeland Hospital, Department of Internal Medicine, Doetinchem.
Lidwine W TickMáxima Medical Centre, Department of Internal Medicine, Veldhoven.
Okke De WeerdtSint Antonius Hospital, Department of Hematology, Nieuwegein.
Bregje Van ZaaneFlevo Hospital, Department of Internal Medicine, Almere.
Marjan J CruijsenCatharina Hospital, Department of Internal Medicine, Eindhoven.
Eduardus F M PosthumaReinier de Graaf Group, Department of Internal Medicine, Delft.
Catharina H M J Van ElssenMaastricht University Medical Center+, Department of Internal medicine, Maastricht, The Netherlands; Research Institute for Oncology and Reproduction (GROW), Maastricht University, Maastricht.
Saskia K KleinUniversity Medical Center Groningen, Department of Hematology, Groningen.
Arjan A Van de LoosdrechtAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam.
David C De LeeuwAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam. d.deleeuw@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40963393
PMCPMC12951139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.